开始
RocketTickers

Vanda Pharmaceuticals Receives FDA Approval to Proceed with Inve

做多
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)  
RocketTickers  
NASDAQ:VNDA   Vanda Pharmaceuticals Inc.
Beyond Technical Analysis
0
0
beyondta
VNDA: Vanda Pharmaceuticals Inc.
2020-10-26 16:01:00
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic Conjunctivitis
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。